BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 14601152)

  • 1. Willingness to pay methods in health care: a sceptical view.
    Cookson R
    Health Econ; 2003 Nov; 12(11):891-4. PubMed ID: 14601152
    [No Abstract]   [Full Text] [Related]  

  • 2. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 3. The contingent valuation method in health care. An economic evaluation of Alzheimer's disease.
    Nocera S; Telser H; Bonato D
    Dev Health Econ Public Policy; 2003; 8():iii-xi, 1-116. PubMed ID: 15027158
    [No Abstract]   [Full Text] [Related]  

  • 4. The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.
    Donaldson C; Birch S; Gafni A
    Health Econ; 2002 Jan; 11(1):55-70. PubMed ID: 11788982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. If the price is right: vagueness and values clarification in contingent valuation.
    Shiell A; Gold L
    Health Econ; 2003 Nov; 12(11):909-19. PubMed ID: 14601154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double discounting of QALYs.
    MacKeigan LD; Gafni A; O'Brien BJ
    Health Econ; 2003 Feb; 12(2):165-9. PubMed ID: 12563665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
    Hansen BO; Hougaard JL; Keiding H; Ă˜sterdal LP
    J Health Econ; 2004 Sep; 23(5):887-98. PubMed ID: 15353184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuing health care using willingness to pay: a comparison of the payment card and dichotomous choice methods.
    Ryan M; Scott DA; Donaldson C
    J Health Econ; 2004 Mar; 23(2):237-58. PubMed ID: 15019754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness and ability to pay for health care: a selection of methods and issues.
    Russell S; Fox-Rushby J; Arhin D
    Health Policy Plan; 1995 Mar; 10(1):94-101. PubMed ID: 10141627
    [No Abstract]   [Full Text] [Related]  

  • 11. Willingness to pay and size of health benefit: an integrated model to test for 'sensitivity to scale'.
    Yeung RY; Smith RD; McGhee SM
    Health Econ; 2003 Sep; 12(9):791-6. PubMed ID: 12950096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory versus practice: a review of 'willingness-to-pay' in health and health care.
    Olsen JA; Smith RD
    Health Econ; 2001 Jan; 10(1):39-52. PubMed ID: 11180568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of a statistical life: theoretical and empirical evidence.
    Johansson PO
    Appl Health Econ Health Policy; 2002; 1(1):33-41. PubMed ID: 14618746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-social welfare functions: a reply to Hansen et al.
    Edlin R
    J Health Econ; 2004 Sep; 23(5):899-905. PubMed ID: 15353185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do ordering effects matter in willingness-to-pay studies of health care?
    Stewart JM; O'Shea E; Donaldson C; Shackley P
    J Health Econ; 2002 Jul; 21(4):585-99. PubMed ID: 12146592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it really possible to build a bridge between cost-benefit analysis and cost-effectiveness analysis?
    Dolan P; Edlin R
    J Health Econ; 2002 Sep; 21(5):827-43. PubMed ID: 12349884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aiding priority setting in health care: is there a role for the contingent valuation method?
    Olsen JA
    Health Econ; 1997; 6(6):603-12. PubMed ID: 9466142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation.
    Smith RD
    Health Econ; 2001 Sep; 10(6):487-97. PubMed ID: 11550290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses.
    Bala MV; Zarkin GA; Mauskopf JA
    Value Health; 2002; 5(4):338-46. PubMed ID: 12102696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Willingness to pay for what? A note on alternative definitions of health care program benefits for contingent valuation studies.
    Currie GR; Donaldson C; O'Bbrien BJ; Stoddart GL; Torrance GW; Drummond MF
    Med Decis Making; 2002; 22(6):493-7. PubMed ID: 12458979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.